 
- 积分
- 306
- 威望
- 306
- 包包
- 3648
|

Nature advance online publication 9 August 2009 | doi:10.1038/nature08235) i" b* m- ?* a9 f- n* E
7 T6 r K& l+ W6 k
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
6 J* w+ q# T4 p3 E* w8 d
. K- }/ g% k" Q1 p1 \9 K1 ~Hyenjong Hong1,2, Kazutoshi Takahashi1, Tomoko Ichisaka1,3, Takashi Aoi1, Osami Kanagawa4, Masato Nakagawa1,2, Keisuke Okita1 & Shinya Yamanaka1,2,3,5
8 ~' k8 Z! p2 L" {8 a8 Z- c c/ v, s7 J+ h8 F* Y+ d
1 Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8507, Japan7 r$ q6 H5 n! {, \5 ^0 x0 s
2 Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
2 d. I" J4 W5 Q0 D% A0 q" ]% }( K6 x3 Yamanaka iPS Cell Special Project, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan
1 ~7 `0 k# J0 V$ A. C1 ?+ _4 Laboratory for Autoimmune Regulation, RIKEN Center for Allergy and Immunology, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan
) r i: U D Z' l' N5 Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, USA* O- g; @: q) J# A3 _% d5 f$ k
; R$ j: L/ Y9 b9 n c# R, ?Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse1, 2, 3, 4 and in human5, 6, 7, 8. The efficiency of this process, however, is low9. Pluripotency can be induced without c-Myc, but with even lower efficiency10, 11. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation12, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53–p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation. |
|